Planning pipeline swells in England, but approvals and new-build delivery still lag behind
A pipeline growing in scale, not just in number
England's residential planning system is sending a mixed signal. Raw application volumes have cooled from their 2021 peak, but the ambition behind each submission has grown sharply. REalyse planning data shows that the total number of residential units proposed across English applications hit its highest level in years in 2025, even though the number of individual applications submitted was broadly flat on 2024 and well below the 2021 high.
That combination — fewer applications, but bigger ones — points to a market where developers and landowners are increasingly bringing forward larger, higher-unit-count schemes rather than a wide spread of small sites. For institutional investors and lenders, this matters: pipeline risk is becoming more concentrated in fewer, larger bets, which raises the stakes of getting site selection, viability and planning risk assessment right.
At the same time, approval rates have been drifting down. REalyse data shows the share of decided applications granted consent fell from around 75% in 2021 to roughly 70% in 2024 and 2025, a modest but persistent softening that compounds the effect of a more concentrated pipeline. Fewer, larger schemes going through a slightly tighter approval filter means more capital sitting at risk in the pre-consent stage for longer.
Where the bottleneck is really biting
The story is not that local authorities have suddenly become dramatically more restrictive — a five-percentage-point drift in approval rates over several years is consistent with resourcing pressure and increased scrutiny on larger schemes rather than a policy shock. The bigger constraint sits further down the pipeline, in the translation of granted consent into homes actually built and sold.
REalyse transaction data on new-build sales shows activity considerably below the volumes implied by recent years of granted consents, even allowing for the normal lag between a decision and a registered sale. This is the gap that matters most commercially: a scheme with planning consent is not revenue, and a stalled or slow-moving site ties up capital, land value and lender exposure without generating the sales comparables that valuations depend on.
For developers, this reinforces the case for stress-testing build-out and absorption assumptions against realistic local comparables rather than the pace implied by planning consent volumes alone. For lenders and credit teams, it is a reminder that a "planning granted" milestone on a loan book is a necessary but insufficient signal of delivery risk — actual sales velocity and days-on-market in the surrounding area remain the better proxy for whether a scheme will convert to cash on the expected schedule.
Regional and scheme-size dynamics worth watching
Because the pipeline is skewing toward larger schemes, local authority capacity and infrastructure planning around major sites become more consequential to overall housing delivery. A handful of large strategic sites failing to progress can move the aggregate England picture more than a broad spread of small planning refusals would.
This is where postcode and district-level analysis earns its keep. Comparing proposed unit volumes, approval rates and build-out pace by local authority and district — rather than looking at the England-wide average in isolation — helps investors and developers spot where pipeline is genuinely converting into delivered stock, and where consented schemes are stalling. Areas with strong demographic and rental demand fundamentals but a thin track record of converting consents into completions may carry more execution risk than the headline planning numbers suggest.
Underwriting implications for investors and lenders
The widening gap between pipeline ambition and delivery has practical consequences for how deals get assessed:
• GDV and absorption assumptions should be benchmarked against actual local sales pace and new-build transaction comparables, not extrapolated from application or consent volumes.
• Concentration risk rises as the pipeline shifts toward fewer, larger schemes — portfolio and loan-book exposure to any single large consented site becomes more material.
• Planning risk pricing may need to reflect the modest but real decline in approval rates, particularly for schemes of unusual scale or density relative to local precedent.
• Comparable-driven valuations — cross-referencing granted schemes against recent achieved sale prices and rents in the immediate area — remain the most reliable check against overly optimistic pipeline-to-delivery timelines.
Outlook
England's housing pipeline is not shrinking — if anything, it is being reshaped into fewer, more ambitious schemes chasing a housing need that has not gone away. But a bigger pipeline on paper does not automatically mean more homes on the ground, and the persistent gap between proposed units and delivered new-build sales is the metric worth watching most closely into 2026.
For developers, lenders and investors, the practical takeaway is to treat planning pipeline data as a starting point for due diligence rather than a proxy for delivery. Cross-referencing consented schemes against local build-out track records, comparable sales and rental performance will remain the sharpest way to separate pipeline that is genuinely on track from pipeline that is simply on paper.










